Researchers have found that a combination of two already-in-use drugs may have an effect on stopping the growth of the most common genetic subtype of lung cancer setting the stage for clinical trials.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/S...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/S...